Next Article in Journal
Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [177Lu]Lu-Satoreotide Tetraxetan and the Agonist [177Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST2-Positive Tumours
Next Article in Special Issue
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein–Protein Interaction between CTLA-4 and B7-1
Previous Article in Journal
Understanding the Physiological Role of Electroneutral Na+-Coupled HCO3 Cotransporter and Its Therapeutic Implications
Previous Article in Special Issue
Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1084; https://doi.org/10.3390/ph15091084
Action Date Notes Link
article pdf uploaded. 30 August 2022 15:32 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1084/pdf-vor
article supplementary file uploaded. 30 August 2022 15:32 CEST - https://www.mdpi.com/1424-8247/15/9/1084#supplementary
article xml file uploaded 31 August 2022 06:24 CEST Original file -
article xml uploaded. 31 August 2022 06:24 CEST Update https://www.mdpi.com/1424-8247/15/9/1084/xml
article pdf uploaded. 31 August 2022 06:24 CEST Updated version of record https://www.mdpi.com/1424-8247/15/9/1084/pdf
article html file updated 31 August 2022 06:25 CEST Original file -
article html file updated 31 August 2022 10:10 CEST Update https://www.mdpi.com/1424-8247/15/9/1084/html
Back to TopTop